GlassScriptPhysician profile
Jared William Colon
NPI 1912490475
$5,062.50
in general payments reported to CMS, 2019-2025
11 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,370 · 2020: $350 · 2021: $1,387 · 2022: $341 · 2023: $1,116 · 2024: $335 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,285 · Education: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,284.95 |
| Education | $329.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $2,250.00 | 2019-2021 | |
| Medical Device Business Services, INC. | $1,508.95 | 2019-2023 | |
| Axogen | $492.52 | 2023-2025 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Stryker Corporation | $255.94 | 2022-2023 | T2 Alpha, Citrefix, Variax |
| Endo USA, INC. | $211.54 | 2024-2025 | Xiaflex |
| Acumed LLC | $120.67 | 2024 | Acumed, Innate Implant |
| Zimmer Biomet Holdings, INC. | $82.65 | 2023 | |
| Fortis Surgical, LLC | $74.89 | 2024-2025 | |
| Bioventus LLC | $26.75 | 2025 | Durolane |
| Skeletal Dynamics INC | $22.75 | 2025 | Implate, Align, Geminus |
| Depuy Synthes Sales INC. | $15.84 | 2024 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Colon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.